Annis Gardner Whiting Capital Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
CIP
Annis Gardner Whiting Capital Advisors's RGEN Position: Q3 2025 in Review
Annis Gardner Whiting Capital Advisors sold out of Repligen (RGEN) in Q3 2025, closing a stake of 90 shares — an estimated $11.2K sold.
Annis Gardner Whiting Capital Advisors first reported a position in RGEN in Q3 2023 and held it in 7 quarters. The position peaked at $185K in Q3 2024. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.
- Annis Gardner Whiting Capital Advisors reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
- Annis Gardner Whiting Capital Advisors sold 90 Repligen shares in Q3 2025, an estimated $11.2K.
- Annis Gardner Whiting Capital Advisors first reported a position in Repligen in Q3 2023 and held it in 7 quarters.
- Annis Gardner Whiting Capital Advisors's Repligen position peaked at $185K in Q3 2024.
- 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.
Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.